Study on Evaluation and Optimization of TCM Regimen of Generalized Anxiety Disorder

Not Applicable

Recruiting

• Conditions: Generalized Anxiety Disorder

• Registration Number: ITMCTR2100004738
• Lead Sponsor: Xuanwu Hospital of Capital Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Subjects aged 18-65 years;
2. Patients with anxiety disorder in accordance with clinical research standards;
3. Subjects who meet the TCM syndrome standards of liver stagnation and fire transforming type, blood stasis and internal resistance type, heart and gallbladder Qi deficiency type;
4. Subjects with stable vital signs have clear mind and certain expression ability;
5. The subjects who signed the informed consent agreed to participate in this study;
Only those who meet the above five criteria can be selected.

Exclusion Criteria

1. Patients with somatic diseases secondary to GAD;
2. Subjects with unstable vital signs;
3. Subjects with severe aphasia, agnosia and inability to communicate;
4. Subjects with anxiety accompanied by other mental diseases (such as depression, obsession, schizophrenia, etc.) diagnosed by western medicine;
5. Known alcoholics or substance dependent subjects;
6. Patients with non anxiety psychosis diagnosed by western medicine;
7. Subjects who used other drugs or therapies to treat anxiety disorder during the trial;
8. Subjects who did not use drugs according to the regulations were unable to judge the efficacy or incomplete information, which affected the efficacy or safety judgment;
9. Subjects who refused to take traditional Chinese medicine and had suicidal behavior;
10. Subjects who had received anti anxiety treatment within one week before the trial;
11. Subjects with severe hepatic and renal insufficiency;
12. Pregnant and lactating women;
Those meeting one of the above criteria will be excluded.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hamilton anxiety scale, HAMA;Evaluation form of TCM Syndromes of Generalized anxiety Disorder;

Secondary Outcome Measures

Name	Time	Method
Montreal Cognitive Assessment, MoCA;Hamilton Depression Scale,HAMD-17;WHOQOL-Bref;